BoomerangFX and DrFirst Partner To Launch E-Prescribing Platform
The platform will focus on aesthetic medicine practices in North America.
BoomerangFX, an international cloud-based SaaS provider of end-to-end practice management solutions for non-insured, private-pay healthcare segments including dermatology, cosmetic surgery, medical spa, cosmetic dentistry, vision care and women's health, announced that it has partnered with health technology pioneer DrFirst to offer clients a unified medication management platform to maximize clinical workflows and patient engagement.
Research suggests that aesthetic medicine is experiencing an explosion in consumer adoption and is proving to be increasingly recession resilient. Cosmetic surgeons and physicians from a variety of disciplines are benefiting from the increased demand for facial and body enhancement procedures utilizing minimally invasive procedures. Recent trends highlight that virtually every age group over 20 years, including both men and women of various socio-economic levels will seek out some form of aesthetic treatment, with the market expected to surpass $125 billion globally in the next 5 years.
Continue reading this story here.
New machine-learning approach could speed precision drug development
The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.
AI-enabled CGM app shows promise for glycemic control, weight management
The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.
